141956-49-2

Upstream product

• 590-92-1 3-Bromopropionic acid 
• 130406-64-3 tricyclo<3.3.1.1^3,7>dec-2-yl *,R^*)>-<2-<(2-amino-2-phenylethyl)amino>-1-(1H-indol-3-ylmethyl)-1-methyl-2-oxoethyl>carbamate 

Downstream Products

• 141956-51-6 -<2-<<2-<<3-(ethoxymethylphosphinyl)-1-oxopropyl>amino>-2-phenylethyl>amino>-1-(1H-indol-3-ylmethyl)-1-methyl-2-oxoethyl>carbamic acid tricyclo<3.3.1.1^3,7>dec-2-yl ester 
• 141956-53-8 -<2-<<2-<<3-(hydroxymethylphosphinyl)-1-oxopropyl>amino>-2-phenylethyl>amino>-1-(1H-indol-3-ylmethyl)-1-methyl-2-oxoethyl>carbamic acid tricyclo<3.3.1.1^3,7>dec-2-yl ester 
• 141980-80-5 -<1-(1H-indol-3-ylmethyl)-1-methyl-2-oxo-2-<<2-<(1-oxo-3-sulfopropyl)amino>-2-phenylethyl>amino>ethyl>carbamic acid tricyclo<3.3.1.1^3,7>dec-2-yl ester monosodium salt 

Relevant academic research and scientific papers

Rationally designed 'dipeptoid' analogues of CCK. Acid mimics of the potent and selective non-peptide CCK-B receptor antagonist CI-988

This paper outlines the synthesis of selected acid mimics of the non- peptide CCK-B selective antagonist CI-988, 1 CCK-B and CCK-A binding affinities of these analogues are described and their CCK-B affinity and selectivity rationalized by consideration o